Associations between polymorphisms in the T102C and A-1438G loci of the 5-HTR2A and the P1763 and P1578 markers of the DTNBP1 gene with the overall productivity and individual subprocesses of shortterm verbal memory were studied in 4–5 patients with schizophrenia and 290 healthy subjects. Subjects were asked to reproduce immediately two lists of 10 words. The overall productivity of reproduction was assessed, along with the reproduction productivity of the first list (immediate memory or general attention), the effect of proactive interference, and the number of intrusions. Patients were significantly different from controls on all measures. Patients showed decreases in overall task performance productivity, in immediate memory productivity, and in the effect of proactive interference; fewer intrusions were seen. Both markers of the 5-HTR2A gene were associated with short-term memory productivity in the combined cohort: assessments were worse in T102C CC and A-1438G GG homozygotes. The P1763 marker of the DTNBP1 gene, conversely, had significant influences on the memory subprocesses reflected in the levels of interference and intrusions but had insignificant influence on overall productivity. Homozygotes for P1763G GG had the worst parameters. Overall, these data are consistent with the concept that these polymorphic genes are involved in different subprocesses of short-term memory both in normal subjects and in patients with schizophrenia.
Similar content being viewed by others
References
M. V. Alfimova, “Mild cognitive disorders in relatives of patients with schizophrenia,” Psikhiatriya, No. 02–04, 75–84 (2006).
V. E. Golimbet, K. K. Manandyan, L. I. Abramova et al., “Allelic polymorphism of the serotonin receptor gene and clinical-pathogenetic features in patients with schizophrenia and schizophrenia spectrum disorders,” Zh. Nevrol. Psikhiat., 100, No. 2, 36–39 (2000).
V. E. Golimbet, M. V. Alfimova, N. G. Mityushina, et al., “Association between the T102C locus of the 5HTR2A gene and the attention and memory functions in patients with schizophrenia,” Med. Gen., No. 7, 340–344 (2004).
M. V. Monakhov, Polymorphic Markers for Genes Associated with the Psychological Signs and Risk of Developing Mental Disorders [in Russian], Author’s Abstract of Master’s Thesis in Biological Sciences, Moscow (2008).
S. N. Mosolov, Psychometric Assessment Scales for the Symptomatology of Schizophrenia and the Concept of Positive and Negative Disorders [in Russian], Moscow (2001).
H. M. Abdolmaleky, S. V. Faraone, S. J. Glatt, and M. T. Tsuang, “Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia,” Schizoph. Res., 67, 53–62 (2004).
A. Aleman, R. Hijman, E. H. F. de Haan, “Memory impairment in schizophrenia: A meta-analysis,” Am. J. Psychiat., 156, 1358–1366 (1999).
A. Brockhaus-Dumke, R. Mueller, U. Faigle, and J. Klosterhoetter, “Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia,” Schizoph. Res., 99, 238–249 (2008).
K. E. Burdick, T. Lencz, B. Funke, et al., “Genetic Variation in DTNBP1 Influences General Cognitive Ability,” Hum. Mol. Genet., 15, 1563–1568 (2006).
K. E. Burdick, T. E. Goldberg, B. Funke et al., “DTNBP1 genotype influences cognitive decline in schizophrenia,” Schizophr. Res., 89, 169–172 (2007).
R. Y. Chen, P. Shan, E. Y. Chen, et al., “No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients,” Psychiat. Res., 105, 175–185 (2001).
M. A. Cirillo and L. J. Seidman, “Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms,” Neuropsychol. Rev., 13, 43–77 (2003).
D. J. F. de Quervain, K. Henke, A. Aerni, et al., “A functional genetic variation of 5-HT2a receptor affects human memory,” Nat. Neurosci., 6, 1141–1142 (2003).
J. DeJong and J. Donders, “A confirmatory factor analysis of the California Verbal Learning Test-Second Edition (CVLT-II) in the standardization sample,” Assessment, 15, 123–131 (2008).
G. Donohoe, D. W. Morris, S. Clarke, et al., “Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study,” Neuropsychologia, 45, 454–458 (2007).
B. Funke, C. T. Finn, A. M. Plocik, et al., “Association of the DTNBP1 locus with schizophrenia in a US population,” Am. J. Hum. Genet., 75, 891–898 (2004).
V. E. Golimbet, M. C. Alfimova, V. G. Kaleda, et al., “Verbal memory deficit in schizophrenia as a possible endophenotype of the disease,” in: Schizoaffective Disorders: New Research, W. H. Murray (ed.), Nova Science Publishers, New York (2006), pp. 165–186.
V. E. Golimbet, O. M. Lavrushina, V. G. Kaleda, et al., “Supportive evidence for the association between the T102C 5-HTR2A gene polymorphism and schizophrenia: a large-scale case-control and family-based study, “Eur. Psychiat., 22, 167–170 (2007).
I. González-Burgos and A. Feria-Velasco, “Serotonin/dopamine interaction in memory formation,” Progr. Brain Res., 172, 603–623 (2008).
M. F. Green, “What are the functional consequences of neurocognitive deficits in schizophrenia?” Am. J. Psychiat., 153, 321–330 (1996).
A. P. Kouzmenko, A. Scaffadi, A. M. Pereira et al., “Schizophrenia and the serotonin-2A receptor promoter polymorphism,” Hum. Hered., 49, 103–105 (1999).
M. J. Parsons, U. M. D’Souza, M. J. Arranz, et al., “The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity,” Biol. Psychiat., 56, 406–410 (2004).
E. M. Peñas-Lledó, P. Dorado, M. C. Cáceres, et al., “Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs,” Clin. Chem. Labour. Med., 45, 835–838 (2007).
Ch. Ranganath, M. J. Minzenberg, and J. D. Ragland, “The cognitive neuroscience of memory function and dysfunction in schizophrenia,” Biol. Psychiat., 64, 18–25 (2008).
C. A. Reynolds, M. Jansson, M. Gatz, and N. L. Pedersen, “Longitudinal change in memory performance associated with HTR2A polymorphism,” Neurobiol. Aging, 27, 150–154 (2006).
F. S. Roman and E. Marchetti, “Involvement of 5-HT receptors in learning and memory,” IDrugs, 1, 109–121 (1998).
A. Serretti, A. Drago, and D. De Ronchi, “HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies,” Curr. Med. Chem.. 14, 2053–2069 (2007).
J. C. Sigmund, C. Vogler, K. D. Huynh, and D. J. de Quervain, “Fine-mapping at the HTR2A locus reveals multiple episodic memory-related variants,” Biol. Psychiat., 79, 239–242 (2008).
G. Spurlock, A. Heils, P. Holmans, et al., “A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter,” Mol. Psychiat., 3, 42–49 (1998).
N. C. Stefanis, T. A. Trikalinos, D. Avramopoulos, et al., “Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level,” Biol. Psychiat., 62, 784–792 (2007).
S. Tosato, M. Ruggeri, C. Bonetto, et al., “Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients,” Am. J. Med. Genet. B. Neuropsychiat. Genet., 144B, 647–649 (2007).
T. Toulopoulou and R. M. Murray, “Verbal memory deficit in patients with schizophrenia: an important future target for treatment,” Expert Rev. Neurother., 4, 43–52 (2004).
M. Wagner, A. Shuhmacher, S. Schwab, et al., “The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans,” Int. J. Neuropsychopharmacol., 9, 1–5 (2008).
J. T. Warren, M. L. Peacock, L. C. Rodrigues, and L. G. Fink, “An Msp1 polymorphism in the human serotonin receptor gene (5HTR2A): Detection by DGGE and FLP analysis,” Hum. Mol. Genet., 2, 338 (1993).
C. S. Weickert, R. E. Straub, B. W. McClintock, et al., “Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain,” Arch. Gen. Psychiat., 61, 544–555 (2004).
J. Williams, G. Spurlock, P. McGuffin, et al., “Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group,” Lancet, 347, 9011 (1996).
M. C. Whyte, A. M. McIntosh, E. C. Johnstone, and S. M. Lawrie, “Declarative memory in unaffected adult relatives of patients with schizophrenia: a systematic review and meta-analysis,” Schizophr. Res., 78, 13–26 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhatrii imeni S. S. Korsakova, Vol. 109, No. 7, pp. 70–75, July, 2009.
Rights and permissions
About this article
Cite this article
Alfimova, M.V., Monakhov, M.V., Abramova, L.I. et al. Polymorphism of Serotonin Receptor Genes (5-HTR2A) and Dysbindin (DTNBP1) and Individual Components of Short-Term Verbal Memory Processes in Schizophrenia. Neurosci Behav Physi 40, 934–940 (2010). https://doi.org/10.1007/s11055-010-9348-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-010-9348-7